These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 1992862)

  • 1. Long-term evaluation of indobufen in peripheral vascular disease.
    Belcaro G; De Simone P
    Angiology; 1991 Jan; 42(1):8-14. PubMed ID: 1992862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indobufen: an updated review of its use in the management of atherothrombosis.
    Bhana N; McClellan KJ
    Drugs Aging; 2001; 18(5):369-88. PubMed ID: 11392445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of indobufen in the treatment of intermittent claudication.
    Signorini GP; Salmistraro G; Maraglino G
    Angiology; 1988 Aug; 39(8):742-6. PubMed ID: 3048153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of indobufen and pentoxifylline on walking capacity and hemostasis in patients with intermittent claudication: results of six months of treatment.
    Panchenko E; Eshkeeva A; Dobrovolsky A; Titaeva E; Podinovskaya Ya; Hussain KM; Karpov Yu
    Angiology; 1997 Mar; 48(3):247-54. PubMed ID: 9071201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of physical exercise and indobufen in patients with intermittent claudication. Results after a 2-year follow-up].
    Binaghi F; Fronteddu PF; Carboni MR; Onnis A; Astara C
    Minerva Cardioangiol; 1991 Jun; 39(6):227-31. PubMed ID: 1961441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Heparan sulphate in association with indobufen in the treatment of chronic peripheral obliterative arteriopathy of the lower extremities. Controlled clinical trial].
    Rossini A; Tascino C; Costa F
    Minerva Cardioangiol; 1998 Nov; 46(11):457-69. PubMed ID: 10207294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-blind, controlled, multicenter study of indobufen versus placebo in patients with intermittent claudication.
    Tönnesen KH; Albuquerque P; Baitsch G; Gomez Alonso A; Ibanez F; Kester RC; Leveson S; Poredos P
    Int Angiol; 1993 Dec; 12(4):371-7. PubMed ID: 8207316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chronic treatment of vascular diseases with indobufen].
    Belcaro G; Errichi BM; Laurora G; Marinucci R; Cesarone MR; De Cenzo A
    Minerva Cardioangiol; 1989 May; 37(5):241-50. PubMed ID: 2779803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of antiplatelet therapy with indobufen or aspirin-dipyridamole on graft patency one year after coronary artery bypass grafting.
    Rajah SM; Nair U; Rees M; Saunders N; Walker D; Williams G; Critchley A; Beton D; Campbell C; Lawson RA
    J Thorac Cardiovasc Surg; 1994 Apr; 107(4):1146-53. PubMed ID: 8159037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indobufen. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in cerebral, peripheral and coronary vascular disease.
    Wiseman LR; Fitton A; Buckley MM
    Drugs; 1992 Sep; 44(3):445-64. PubMed ID: 1382938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinico-hematological evaluation of 57 patients undergoing antiaggregant treatment with indobufen].
    Andriani A; Mosiello G; Chiappetta MG; Gregori G; Rinaldi P
    Recenti Prog Med; 1990 Jan; 81(1):49-53. PubMed ID: 2236828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indobufen compared with aspirin and dipyridamole on graft patency after coronary artery bypass surgery: results of a combined analysis.
    Cataldo G; Heiman F; Lavezzari M; Marubini E
    Coron Artery Dis; 1998; 9(4):217-22. PubMed ID: 9649928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indobufen versus dipyridamole plus aspirin in the treatment of patients with peripheral atherosclerotic disease.
    Fabris F; Steffan A; Randi ML; Avruscio GP; Cordiano I; Girolami A
    J Med; 1992; 23(2):81-92. PubMed ID: 1512524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction by indobufen of neutrophil activation in peripheral arterial occlusive disease.
    Chello M; Mastroroberto P; Celi V; Romano F; Marchese AR; Colonna A
    J Cardiovasc Pharmacol; 1996 Mar; 27(3):417-23. PubMed ID: 8907804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of indobufen on aortocoronary bypass patency after 1 week and after 1 year].
    Rohn V; Pirk J; Mach T
    Cor Vasa; 1993; 35(4):162-4. PubMed ID: 8403942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effect of indobufen on patency in femoro-popliteal/crural bypass using artificial grafts].
    Cernak I; Lotina S; Davidović L
    Vojnosanit Pregl; 1994; 51(3):214-9. PubMed ID: 8560834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A randomized controlled trial of indobufen versus aspirin in the prevention of bridging restenosis after coronary artery bypass grafting].
    Bai C; Li JX; Yu Y; Liu R; Gao MX; Zhang F; Li HY
    Zhonghua Xin Xue Guan Bing Za Zhi; 2022 May; 50(5):466-470. PubMed ID: 35589595
    [No Abstract]   [Full Text] [Related]  

  • 18. Influence of indobufen on occlusion of arteriovenous fistulas and some platelet activity in intermittent peritoneal dialysis patients.
    Dmoszyńska A; Janicki K; Janicka L; Przesmycki K; Sokołowska B; Walter-Croneck A
    Pol J Pharmacol; 1996; 48(3):327-9. PubMed ID: 9112671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indobufen in the prevention of thromboembolic complications in patients with heart disease. A randomized, placebo-controlled, double-blind study.
    Fornaro G; Rossi P; Mantica PG; Caccia ME; Aralda D; Lavezzari M; Pamparana F; Milanesi G
    Circulation; 1993 Jan; 87(1):162-4. PubMed ID: 8419003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clopidogrel plus indobufen in acute coronary syndrome patients with hypersensitivity to aspirin undergoing percutaneous coronary intervention.
    Barillà F; Pulcinelli FM; Mangieri E; Torromeo C; Tanzilli G; Dominici T; Pellicano M; Paravati V; Acconcia MC; Gaudio C
    Platelets; 2013; 24(3):183-8. PubMed ID: 22646157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.